Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Vertex Pharmaceuticals Inc. (VRTX) shares rose 3.48% to $496.83 on a day when the overall stock market declined, with the S&P 500 down 0.43% and the Dow Jones down 1.05%. This increase ended a two-day losing streak, although the stock remains 4.40% below its 52-week high of $519.68. Compared to competitors, Vertex outperformed AbbVie Inc. (up 3.29%), while Krystal Biotech Inc. and Arcturus Therapeutics Holdings Inc. saw declines.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments